Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE
dabigatran etexilate
1160.63
NCT00558259
Venous Thromboembolism
Phase 3
 
January 2015

Powered by ideaPoint, Inc.